NEW
Font size
WorksheetsCML & PV Hema
Total questions: 14
Worksheet time: 14mins
A peripheral blood film that shows increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:
AML
CML
MDS
Multiple myeloma
Which of the following chromosome abnormalities is associated with CML?
t (15;17)
t (8;14)
t (9;22)
Monosomy 7
A patient has a platelet count of 700 X 109 /L with abnormalities in the size, shape, and granularity of platelets; a WBC count of 12 X 109 /L; and hemoglobin of 11 g/dL. The Philadelphia chromosome is not present. The most likely diagnosis is
PV
ET
CML
Leukemoid reaction
The peripheral blood in PV typically manifests:
Erythrocytosis only
Erythrocytosis and thrombocytopenia
Erythrocytosis, thrombocytosis, and granulocytosis
Anemia and thrmbocytopenia
The most common mutation found in patients with primary PV is:
BCR - ABL1
Philadelphia chromosome
JAK2 V617F
t (15;17)
A patient in whom CML has previously been diagnosed has circulating blasts and promyelocytes that total 30% of leukocytes. The disease is considered to be in what phase?
Chronic stable phase
Accelerated phase
Transformation to acute leukemia
Temporary remission
A patient has a WBC count 30 X 10^9 /L and the following WBC differential count:
Segmented neutrophils - 38%
Bands - 17%
Metamyelocytes - 7%
Promyelocytes - 10%
Eosinophils - 3%
Basophils - 5%
Which of the following test results would be helpful in determining whether the patient has CML?
Nitroblue tetrazolium reduction product increased
Myeloperoxidase increased
Periodic acid - Schiff staining decreased
FISH positive for BCR-ABLI fusion
Complications of ET include all of the following except:
Thrombosis
Hemorrhage
Seizures
Infections
Which of the following patterns is characteristic of the peripheral blood in patients with PMF?
Teardrop-shaped erythrocytes, nucleated RBCs, immature granulocytes
Abnormal platelets only
Hypochromic erythrocytes, immature granulocytes, and normal platelets
Spherocytes, immature granulocytes, and increased numbers of platelets
this mutation is observed in 50% to 60% of patients with ET and PMF and contributes to the pathogenesis of the disorders
JAK2 V617F
PCM1-JAK2
T315I
PDGFRA
The myelofibrosis associated with PMF is a result of:
Apoptosis resistance in the fibroblasts of the bone marrow
Impaired production of normal collagenase by the mutated cells
Enhanced activity of fibroblasts as a result of increased stimulatory cytokines
Increased numbers of fibroblasts as a result of cytokine stimulation of the pluripotential stem cells
no longer considered an MPN and is divided into three subcategories
Mastocytosis
Microcytosis
Leucocytosis
Anisocytosis
is currently treated with phlebotomy, hydroxyurea, and low-dose aspirin; and in the future JAK2 inhibitors will be a treatment alternative.
ET
PV
AML
CML
Approximately 4% of CML patients given ______ as firstline therapy develop imatinib resistance.
asciminib
retinoic acid
indirubin
imatinib
